Differential cellular immune responsiveness to systems of the major histocompatibility complex
- PMID: 55429
- DOI: 10.1016/0091-6749(76)90029-4
Differential cellular immune responsiveness to systems of the major histocompatibility complex
Abstract
Antigens determined by genes of the major histocompatibility complex can be divided into two systems" the LD (lymphocyte-defined or L determinant) and SD (serologically defined or S determinant) antigens. This division is based on the differential cellular responsiveness to these two sets of antigens of two subpopulations of T lymphocytes: a proliferating helper cell responds primarily to the LD antigens while a cytotoxic T lymphocyte responds most strongly to the SD antigens.
Similar articles
-
SD vs. LD antigens as targets for lymphocyte-mediated cytotoxicity: study of a family presenting a recombination event within the MHR.Transplant Proc. 1973 Dec;5(4):1679-82. Transplant Proc. 1973. PMID: 4130076 No abstract available.
-
Genetics of transplantation: the major histocompatibility complex.Annu Rev Genet. 1976;10:319-39. doi: 10.1146/annurev.ge.10.120176.001535. Annu Rev Genet. 1976. PMID: 138383
-
The H-2 major histocompatibility complex and the I immune response region: genetic variation, function, and organization.Adv Immunol. 1975;20:125-95. doi: 10.1016/s0065-2776(08)60208-4. Adv Immunol. 1975. PMID: 47219 No abstract available.
-
Relevance of major human histocompatibility determinants in clinical bone marrow transplantation.Transplant Proc. 1976 Dec;8(4):581-9. Transplant Proc. 1976. PMID: 63170 Review. No abstract available.
-
On the relationship between initiator and effector cells in the response to major tansplantation antigens.Transplant Proc. 1973 Dec;5(4):1451-6. Transplant Proc. 1973. PMID: 4130057 Review. No abstract available.
Cited by
-
CD134-allodepletion allows selective elimination of alloreactive human T cells without loss of virus-specific and leukemia-specific effectors.Biol Blood Marrow Transplant. 2008 May;14(5):518-30. doi: 10.1016/j.bbmt.2008.02.010. Biol Blood Marrow Transplant. 2008. PMID: 18410894 Free PMC article.
-
The cyclin dependent kinase inhibitor (R)-roscovitine mediates selective suppression of alloreactive human T cells but preserves pathogen-specific and leukemia-specific effectors.Clin Immunol. 2014 May-Jun;152(1-2):48-57. doi: 10.1016/j.clim.2014.02.015. Epub 2014 Mar 12. Clin Immunol. 2014. PMID: 24631965 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials